Chris Pescott
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 19, 2025
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.Philipp Ivanyi, Ash Bullement, Andrea Botticelli
|Jan 27, 2021
Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer.Chris P Pescott, Emmanuelle Boutmy, Michael Batech
|Oct 29, 2020
Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population.Francois-Xavier Lamy, Michael Batech, Emmanuelle Boutmy
|Jan 07, 2020
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study.Sebastian Stintzing, Ilse van Oostrum, Chris P Pescott
|Jan 26, 2019
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma.Ash Bullement, Paul Nathan, Anna Willis
Pageof 1
Frequent Collaborators
2 joint publications
Francois-Xavier Lamy
2 joint publications
Michael Batech
2 joint publications
Emmanuelle Boutmy
2 joint publications
Ash Bullement
1 joint publications
Bart Heeg
1 joint publications
Viviana Annibali
1 joint publications
Jaesh Naik
1 joint publications
Paul Nathan
1 joint publications
Anna Willis
1 joint publications
Amerah Amin
